title: Efavirenz-rifampicin interaction: therapeutic drug monitoring to efavirenz dosage optimization in HIV/TBC patients.
authors.forename: Salvador E
authors.initials: SE
authors.lastname: Cabrera
authors.forename: Miguel
authors.initials: M
authors.lastname: Cordero
authors.forename: Alicia
authors.initials: A
authors.lastname: Iglesias
authors.forename: María P
authors.initials: MP
authors.lastname: Valverde
authors.forename: Alfonso
authors.initials: A
authors.lastname: Domínguez-Gil
authors.forename: María J
authors.initials: MJ
authors.lastname: García
mesh_terms: D000328:Adult; D000480:Alkynes; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D048588:Benzoxazines / Q000627:therapeutic use*; D003521:Cyclopropanes; D004347:Drug Interactions; D016903:Drug Monitoring; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010597:Pharmacogenetics; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000480:Alkynes; D000904:Antibiotics, Antitubercular; D048588:Benzoxazines; D003521:Cyclopropanes; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz; D012293:Rifampin